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ABSTRACT
Dysosteosclerosis (DSS), an extremely rare dense bone disease, features short stature and fractures and sometimes optic atrophy, cranial
nerve palsy, developmental delay, and failure of tooth eruption in infancy or early childhood consistent with osteopetrosis (OPT). Bone
histology during childhood shows unresorbed primary spongiosa from deficient osteoclast action. Additionally, there is remarkable
progressive flattening of all vertebrae and, by adolescence, paradoxical metaphyseal osteopenia with thin cortical bone. Reports of
consanguinity indicate autosomal recessive inheritance, yet more affected males than females suggest X-linked recessive inheritance.
Weinvestigatedanonconsanguineous girlwithDSS.Osteosclerosiswasdiscoveredatage7months.Ourstudies,spanningages11to44
months, showed weight at approximately 50th percentile, and length diminishing from approximately 30th percentile to –2.3 SD. Head
circumference was þ4 SD. The patient had frontal bossing, blue sclera, normal teeth, genu valgum, and unremarkable joints.
Radiographs showed orbital and facial sclerosis, basilar thickening, bone-in-bone appearance of the pelvis, sclerotic long bone ends,
and fractures of ribs and extremities. Progressive metaphyseal widening occurred as vertebrae changed from ovoid to flattened and
became beaked anteriorly. A hemogram was normal. Consistent with OPT, serum parathyroid hormone (PTH) concentrations reflected
dietary calcium levels. Serum bone alkaline phosphatase, osteocalcin, and TRACP-5b were subnormal. The iliac crest contained excessive
primary spongiosa and no osteoclasts. No mutations were identified in the splice sites or exons for the genes encoding chloride channel
7,T-cellimmuneregulator 1,OPT-associatedtransmembraneprotein1,andmonocytecolony-stimulatingfactor(M-CSF)anditsreceptor
C-FMS, ANKH, OPG, RANK, and RANKL. Genomic copy-number microarray was unrevealing. Hence, DSS is a distinctive OPT of unknown
etiology featuring osteoclast deficiency during early childhood. How osteopenia follows is an enigma of human skeletal pathobiology.
 2010 American Society for Bone and Mineral Research.
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Introduction
D
ysosteosclerosis (DSS; OMIM % 224300)
(1) refers to an
extremely rare disorder characterized in 1968 by Spranger
and colleagues
(2) that presents in infancy or early childhood and
featuresdiffuseosteosclerosiswithexpandedendsofthetubular
bonesandplatyspondyly. Inkeepingwithatypeofosteopetrosis
(OPT),
(3) bone histology during childhood shows unresorbed
primary spongiosa and therefore deficient osteoclast action.
(4,5)
The skeleton is dense but brittle. Patients develop short stature
andfractures and cansuffer optic atrophyand sometimes cranial
nerve palsy, developmental delay, and failure of tooth erup-
tion,
(1,6–9) in keeping with ‘‘marble bone disease.’’
(3) MRI has
suggested delayed myelination in the brain,
(10) seizures have
occurred,
(11) and various skin lesions have been reported.
(11–14)
Consanguinity
(2,6,12,13,15) and a greater number of affected males
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2527(including in two generations) than females
(11) suggest that DSS
can be either an autosomal recessive trait
(1,15) or an X-linked
recessive trait,
(11) but the genetic defect(s) is not known.
(1)
The clinical course and prognosis of DSS are not well
understood. In 1978, Houston and colleagues
(6) reported a
15-year-old boy whose iliac crest histology at 20 months of age
revealed unresorbed primary spongiosa consistent with OPT.
Subsequently, however, metaphyseal widening and sclerosis of
early childhood changed to greater metaphyseal expansion
(extending into the diaphysis) with remarkable osteopenia
and cortical thinning by adolescence. In 2008, his follow-up
at age 44 years was reported by Lemire and Wiebe,
(16) who
documented persistence of the widened proximal and distal
ends of the long tubular bones with central diaphyses that were
not expanded and showed cortical thickening.
Here, we describe our clinical, biochemical, radiologic,
histopathologic, and genetic investigation of a young girl with
DSS and review the pertinent literature.
Materials and Methods
Informed written consent for all studies was obtained as
approved by the Human Research Protection Office, Washington
University School of Medicine (St Louis, MO, USA).
Case Report
This 44-month-old American girl was admitted to our research
center at ages 11, 23, 25, and 35 months. Additional outpatient
serum and urine specimens were obtained at ages 27, 30, and 44
months.
Medical history
The patient was born vaginally at 38 weeks’ gestation to a 37-
year-old G3,P 3,A 0 woman. Birth weight was low for gestational
age at 5 pounds, 14 ounces, but length 19½ inches.
At 5 months of age, computed tomography (CT) for
rapidly increasing head circumference (25th percentile at
birth, 97th percentile at age 5 months, despite growth at
50th percentile for both length and weight) reportedly showed
prominent ventricles, sulci, and subarachnoid spaces but no
space-occupying lesion or hemorrhage.
At7monthsofage,aradiograph(seebelow)forposttraumatic
arm pain prompted a skeletal survey showing metaphyseal
sclerosis that was attributed to ‘‘rickets.’’ Vitamin D was
prescribed but not taken.
From birth to 8 months of age, the patient had recurrent ear
and skin infections and abdominal discomfort believed from
colic.
Between 8 and 11 months of age, several episodes of joint-
centered limb pain were thought to be from dislocations. On
referral to us at age 11 months, psychomotor development was
on time. Tooth eruption was not delayed.
At age 20 months, the patient fractured her distal left femur
during a fall. Healing was delayed in a full splint.
Ophthalmologic exam was normal at age 28 months.
Audiometry had not been performed, but she seemed to hear
well, had clear speech, and was bilingual.
At age 30 months, she fractured through dense metaphyseal
bone in her right radius and ulna during a fall. Reportedly,
healing was slow (casted for 3 months). Parental recollection of
further breaks was negative, but radiographs showed previous
fractures. Morning stiffness in her lower limbs lasted 2 to 3hours
each day. She had chronic nasal ‘‘stuffiness.’’ Several episodes of
erythematous papules involved her lower abdomen and were
always onat leastone areaof her body butusually her belly, legs,
or arms. Episodes lasted 3 to 4 days, were not associated with
fever, and did not hurt or itch.
At 36 months, she fell and fractured her distal right femur,
where dense metaphyseal and more normal-appearing diaphy-
seal bone joined. Healing was delayed in a long-leg cast for 3
months.
She received acetaminophen for nighttime fussiness but no
multivitamins or supplements. She drank filtered municipal tap
water. There were no factories near her home, but lead paint had
been removed from a nearby house.
At age 44 months (32 = 3 years), interval history revealed a
fractured leftfemur fromafallonto acarpetedfloor withdelayed
healing while casted. Subsequently, however, the patient could
run. There was generalized morning stiffness and painful ribs.
Her healthy brothers were 6 and 8 years old. The family history
was negative for skeletal disease or parental consanguinity. The
father was of Turkish descent. The mother’s family emigrated to
Turkey from Greece 70 years previously.
Physical findings
When examined for diagnosis at age 11 months, the patient had
a high forehead, frontal bossing, blue sclerae, a flattened nasal
bridge, downturned mouth (Fig. 1A), a narrow and high-arched
palate, and a wide palatine ridge with nine normal-appearing
teeth, indicating no delay in tooth eruption. Joint range of
motion was full. A dermatosis involved her lower abdomen
(Fig. 1B).
At age 22 months, she had no palpable cranial sutures, bony
tenderness,orgenuvalgum.Although50thpercentileforweight
and length at age 5 months, between 11 and 35 months of age
she maintained her weight at approximately 30th percentile of
normal, but length decreased from approximately 30th percentile
to below the growth curve (Z-score¼–2.5). The upper/lower
body segment Z-score increased to greater than 2.0. Arm span
was less than 5th percentile. Head circumference Z-score
decreased from þ4.3 to þ3.6. Genu valgum was present
radiographically as early as 22 months of age.
At age 44 months, weight was approximately 59th percentile,
and length was –2.3 SD. Arm span versus height had progressed
initially along the 50th percentile, but arm span measurements
now showed that her arms were disproportionately short.
(23)
Biochemical testing
Fasting blood was used for all in-patient studies. Biochemical
profiles were obtained from our Dade Behring Dimension Xpand
instrument (Siemens Health Care Diagnostics, Inc., Los Angeles,
CA, USA) using the reference ranges provided by the
manufacturer. However, for all key findings, results were
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2007 from 34 healthy children and 24 healthy adults.
(17)
At age 11 months, the patient was given a diet containing
approximately 400mg of calcium per day to match her home
intake estimated from a 7-day food record [Recommended Daily
Allowance (RDA) for age¼270mg]. At age 23 months, intake
was approximately 950mg. At age 35 months, we reduced her
calciumintaketo775mgdaily(RDAof500mgrecommended)to
prevent suppressed serum parathyroid hormone (PTH) levels
(see ‘‘Results’’).
To explore whether DSS is an OPT, we assayed serum levels of
the brain isoenzyme of creatine kinase, BB-CK (Kit K20, Sebia,
Norcorss, GA, USA),
(18) tartrate-resistant acid phosphatase
(TRACP-5b, Kit 8033, Quidel, Los Angeles, CA, USA),
(17) and
lactate dehydrogenase (LDH) and aspartate aminotransferase
(AST).
(17)
Skeletal remodeling was assessed by quantitating serum
bone-specific alkaline phosphatase (BAP) using ELISA (Quidel
Corp., San Diego, CA, USA) and osteocalcin (Kit LKON1, Siemens
Health Care Diagnostics, Inc.) and urine free deoxypyridinoline
(DPD, Immulite 1000 Pyrilinks, D Kit, Siemens Medical Solutions
Diagnostics, Ltd., Lianberis, Gwynedd, UK).
Radiologic studies
All radiologic studies, including images obtained elsewhere,
werereviewed toassess thenatureand evolutionofthe patient’s
skeletal disease, including fractures and their rate of healing.
Dual-energy X-ray absorptiometry (DXA) of the patient and her
parents involved a Hologic QDR 4500-A instrument (Hologic
Corp., Waltham, MA, USA).
Histopathologic studies
At 2 years of age, two 3-day oral courses of demeclocycline
separatedby10dayswereingested.Twodaysafterthelastdose,
a transapophyseal iliac crest biopsy was performed using a Trap-
Lok needle (Medical Device Technologies; Gainesville, FL, USA).
The specimen was fixed in 70% ethanol and 30% water,
embedded without decalcification in methyl methacrylate, and
cut into 5-mmsections for stainingvia the hematoxylin andeosin
(H&E), toluidine blue, and von Kossa methods. Unstained 10-mm
sections were used for fluorescence microscopy.
Mutation analyses
Three genes (exons and mRNA splice sites) associated with OPT
[chloride channel 7 (CLCN7), T-cell immune regulator 1 (TCIRG1),
and OPT-associated transmembrane protein 1 (OSTM1)] had
been studied at Connective Tissue Gene Tests (Allentown, PA,
USA).We purified genomic DNAfrom blood leukocytes using the
Gentra Puregene DNA extraction kit (Invitrogen, Carlsbad, CA,
USA) and examined all coding exons and adjacent mRNA splice
sites of TNFRSF11A encoding RANK, TNFRSF11B encoding OPG,
and TNFSF11 encoding RANK ligand (RANKL) by PCR and
sequencing in both directions using published methods and
primers.
(19–21) Because few osteoclasts were noted on our
patient’s iliac crest biopsy, the CSF1 and CSF1R genes encoding
monocyte colony-stimulating factor (M-CSF) and its receptor
C-FMS, respectively, were examined using primers and condi-
tions that we developed (available on request). Furthermore,
her bone modeling disturbances and the literature report of
resolution of long bone osteosclerosis in DSS
(6,16) led us to study
the ANKH gene deactivated in craniometaphyseal dysplasia.
(22)
DNA sequences were evaluated using AlignX software (Vector
NTI, Invitrogen) and by inspecting electropherograms.
Genomic DNA copy-number microarray analysis of the
proband and parents was performed using the Affymetrix SNP
6.0 chip at the Laboratory for Clinical Genomics, Washington
University School of Medicine (St Louis, MO, USA) and the Partek
Genomics Suite (Partek, St Louis, MO, USA).
Fig. 1. Patient. (A) At age 44 months, there is frontal bossing, a small
midface, low-set ears, and blue sclerae. (B) At age 3 years, the recurring
dermatosis (arrow) is present on the lower abdomen.
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We assessed all previous reports of DSS using original
publications obtained from the Becker Library of Medicine,
Washington University School of Medicine (St Louis, MO, USA),
especially the radiographic reproductions.
Results
Biochemical testing
Serum ionized calcium was highest, 5.3mg/dL (normal 4.7 to
5.3mg/dL), during the first admission at age 11 months (Table 1),
when her estimated dietary intake of calcium significantly
exceeded the RDA. With less dietary calcium, serum generally
contained lower total and ionized calcium concentrations, but
PTH levels fluctuated considerably over ages 11 to 44 months,
ranging from 7 to 120pg/mL (normal 4 to 52pg/mL; Table 1).
Calcium in timed urine collections ranged from 196 to 241mg/g
of creatinine (Cr).
Serum 25-hydroxyvitamin D [25(OH)D] was 28ng/mL (normal
32 to 100ng/mL) (Lab Corp., Burlington, NC, USA), with normal
levels of magnesium and inorganic phosphate.
Serum alkaline phosphatase (ALP) decreased to as low as 125
IU/L (normal 157 to 477 IU/L) and was intermittently subnormal
for age, especially in view of recurrent fractures. Serum BAP,
osteocalcin, and TRACP-5b levels all were consistently low
(Table 1). Urine free DPD was 18 nmol/mmol of Cr (23 months)
and 14 nmol/mmol of Cr (44 months) (normal 7 to 34 nmol/
mmol).
Serum BB-CK, LDH, and AST levels were unremarkable, unlike
in some OPTs where elevated values can occur.
(17,18) Urine did
not contain heavy metals. Serum was negative for lead (Legacy
Laboratory Services, Portland, OR, USA).
At ages 23, 35, and 44 months, complete blood counts were
normal, including monocytes. Erythrocyte sedimentation rate
seemed elevated for a child at 18, 15, and 24mm/h, respectively
(normal 0 to 20mm/h for young adults), and serum C-reactive
protein was consistently normal. Serum contained elevated IgG
of1416mg/dL(normal453to916mg/dL)andslightlyhighIgAof
111mg/dL (normal 20 to 100mg/dL) (Lab Corp.).
Radiologic findings
Radiographic skeletal surveys were available from ages 7, 11, 22,
and 33 months. Right hand and wrist films were available at
30 months, left knee at 42 months, and right knee at 47 months.
A generalized skeletal disorder was revealed, where every
imaged bone was abnormal (Figs. 2 through 5). Prominent
findings included basilar sclerosis of the skull and modeling
abnormalities (expansion) in the major long bones resembling
OPT but also ovoid vertebral bodies characteristic of DSS. The
sclerosis must have occurred postnatally because relatively
normal iliac bones had formed in utero that subsequently
became sclerotic peripherally. The changes per anatomic site are
described below.
Axial skeleton
Skull
The neurocranium at ages 22 and 33 months was large, resulting
in craniofacial disproportion (Fig. 2). The frontal bone bulged
anteriorly; the midface was small. The posterior fossa appeared
prominent. Sutures were normal. Closure of the anterior
fontanelle seemed delayed (open at 22 months; virtually closed
at 33 months). The ascending ramus of the mandible was smaller
than expected, and the mandibular angle was obtuse. Some
teeth were malformed or abnormally oriented. The skull base
was sclerotic, increasing between 7 to 33 months. Periorbital
sclerosis was especially prominent along with sclerosis of the
greater and lesser wings of the sphenoid and the posterior
portion of the sphenoid body. Maxillary and ethmoid sinuses
were opaque at ages 22 and 33 months, and the mastoid air cells
were small.
Head CT
At age 5 months, CT showed a sclerotic skull base but no hy-
drocephalus or intracranial calcifications. The sulci were slightly
enlarged. There was a suggestion of abnormal myelination.
The optic foramina, middle ears, and internal auditory canals
appeared grossly normal, but detailed optic foramina and
petrous bone imaging was not obtained. Multiple follow-up CTs
elsewhere were essentially unchanged.
Table 1. Longitudinal Biochemical Findings
Age
(mos.)
Serum
Total Ca Ca
2þ PTH Pi ALP BAP Osteocalcin TRACP-5b
(normal
8.9–10.2mg/dL)
(normal
4.7–5.3mg/dL)
(normal
4–52pg/mL)
(normal
3.4–5.9mg/dL)
(normal
157–477IU/L)
(normal
88–247U/L)
(normal
37–119ng/mL)
(normal
13–23U/L)
11 10.1 5.3 34 4.7 213 — 9 8
23 10.2 5.2 33 5.0 162 — 2 —
25 9.1 4.9 120 4.5 210 85 12 2
27
  10.1 — 7 5.2 125 — — —
30
  10.0 — 38 4.6 140 — — —
35 9.9 5.0 62 4.2 136 41 12 3
44
  9.8 5.0 22 4.4 176 63 6 3
— ¼not done.
 ¼non-fasting outpatient serum.
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Chest shape was normal, but the ribs were broad and diffusely
sclerotic with multiple lower rib fracture deformities at age
7 months. By age 22 months, the ribs were more sclerotic, the
medullary cavities were delayed (because they were just
beginning to form), and there were multiple healed fractures
that had become more numerous in the fifth through the
eleventh ribs bilaterally. The ribs were shortened with a
modeling error anteriorly, and wide anteriorly and laterally
(Fig. 3A). Fractures had occurred anteriorly and laterally and were
not remodeling. At 33 months, the ribs were still sclerotic and
widened, and they had more recent fractures and multiple
fracture deformities but were showing further medullary cavity
development. The clavicles were sclerotic, and their medial ends
widened at ages 22 and 33 months. The sternal segments were
broad and sclerotic, with a central lucency, as were the scapulae.
The heart and lungs appeared normal.
Fig. 3. Spine. This anteroposterior projection (A) at 22 months shows sclerotic vertebrae, dense ribs with healing fractures, sclerotic medial clavicles, and
bone-in-bone appearance in the ilium as seen in some forms of OPT. Between 7 (B) and 33 (C) months of age, the lateral spine shows sclerosis and
flattening ofvertebralbodiesthat increasedwith age.The vertebralbodieshavea pointedconfiguration anteriorly (greatestat 7 months). Sclerosisaffects
the entire vertebra.
Fig. 2. Skull. (A) At age 22 months, anteroposterior view of the skull shows sclerosis that affects the periorbital region and skull base. The sinuses are
opacified. (B) At age 33 months, the neurocranium appears large on lateral view, with diffuse sclerosis greatest at the base. The midface is small, and the
mandibular angle is obtuse.
DYSOSTEOSCLEROSIS AND OSTEOPETROSIS Journal of Bone and Mineral Research 2531Pelvis
Sclerosis was accompanied by a normal-appearing central por-
tion of the iliac bones causing a ‘‘bone in bone’’ appearance at
age 22 months (Fig. 3A), and even more apparent at 33 months.
The upper iliac borders were irregular. The ischial and pubic
bones were sclerotic. The femoral heads and metaphyses were
sclerotic, and the necks were wide with failure of modeling.
Spine
The vertebral bodies were sclerotic, with the cranial and caudal
ends appearing ‘‘sandwich-like,’’ and their anterior margins were
pointed anteriorly. Compared with age 7 months, when the
lumbar vertebrae had a more oval shape (Fig. 3B), vertebral body
flattening was more striking at age 22 months, and at 33 months
the vertebral bodies showed rectangular shapes with greater
relative flattening (Fig. 3C). There was some anterior vertebral
notching. The disk spaces were relatively widened. The neural
arches also were sclerotic. A pars defect, in keeping with an
OPT,
(24) was observed at L4, but healed by 33 months.
Appendicular skeleton
Extremities
The overall pattern was one of sclerosis focused primarily on the
metaphyses that also were expanded (Fig. 4).
Tubulation failure was best seen in the distal femurs (Fig. 4A,
B). By 33 months, this expansion extended almost to the
midshafts.Theexpansion,whichwasgreatestinthemetaphyses,
extended into the diaphyses and from sclerotic bone into
nonsclerotic bone. Between the ages of 7 and 43 months, the
dense sclerosis at the ends of the bones increased appreciably in
length. Some areas of metaphyseal sclerosis were sharply
demarcated at the diaphysis, whereas others appeared to fade
into more normal-appearing bone. There was a healing fracture
in the distal left femur at the junction of the sclerotic and
nonsclerotic bone, shown by periosteal new bone formation and
focal expansion of the bone (Fig. 4A). The rate at which extremity
fractures healed was delayed. Fractures continued to occur.
Transverse lucent areas that were small and faint were seen in
the dense sclerosis of some metaphyses, such as the distal femur
(Fig. 4E).
In the proximal end of the humeral metaphyses and both
distal radii and ulnas, between 7 and 33 months of age, there
were well-demarcated areas of dense sclerosis that increased in
length (Fig. 4C, D). The junctions between the sclerotic and
nonsclerotic bone were varied, being transverse, oblique, and
rounded. The cortices in the midshafts were thickened. The
proximal humeri and the distal radii and ulnas showed best the
irregularity of the provisional zones of calcification at the physeal
plates (Fig. 4C, D). The epiphyses were sclerotic.
Hands and feet
Sclerosis was greatest in the metacarpals, metatarsals, and distal
radii and ulnas and often most in their metaphyses (Fig. 5).
Nevertheless, metacarpals and metatarsals contained nonsclero-
ticareas.Somephalangeswerealmostentirelysclerotic, whereas
others appeared normal. In some, metaphyseal sclerosis
terminated abruptly into more normal-appearing bone, and
then into a mixed sclerosis pattern. The cuboids had focal
sclerosis, as did some other tarsal bones, but the carpals and
distal radial epiphyses had no sclerosis. The distal radii and ulnas
showed irregular physeal plates, provisional zones of calcifica-
tion, and broad undertubulated, densely sclerotic metaphyses
where the sclerosis terminated abruptly into more normal-
appearing bone (Fig. 5D). In addition, the sclerosis ended in a
rounded or oblique shape. The second metacarpals had
accessory epiphyses. The bone age at 22 months was delayed
to 18 months. At 33 months, the metaphyses of the phalanges
were more sclerotic, as were the epiphyses.
At age 3 years, DXA L1–L4 spine BMD Z-score was þ8.1.
Fractures
Fractures would occur through radiographically dense bone
(Fig. 5D) or at the junction of osteosclerosis and less remarkable
bone (Fig. 5E) and were slow to heal.
Histopathologic findings
Transapophyseal iliac crest biopsy showed a disordered growth
plate consistent with the findings in some appendicular
radiographs (see above). Specifically, the physis had zones of
chondrocytes with normal proliferative and hypertrophic
morphologies (Fig. 6A), but the cells were not arranged in their
usual columnar orientation. An area deep to the growth plate,
which at the patient’s age is normally composed of trabecular
bone with modest amounts of centrally located cartilage
remnants, consisted almost entirely of calcified cartilage, as
shown by H&E, toluidine blue, and von Kossa stains (Fig. 6,B–D).
There was replacement of trabecular bone by calcified cartilage
and diminished numbers of hematopoietic cells. Fluorescence
imaging of unstained sections (not shown) demonstrated diffuse
uptake of demeclocycline in areas of calcified cartilage near the
growth plate, but there were no linear single or double labels to
indicate normal bone formation. The area between the calcified
cartilage contained primarily mesenchymal cells (ie, osteoblasts
and fibroblasts), with only rare hematopoietic cells. Osteoclasts
were not identified morphologically or by TRAP staining (Fig. 6E).
Overall, the findings of increased amounts of cartilage, decreas-
ed hematopoietic marrow, and an absence of identifiable
osteoclastswereconsistentwithaformof‘‘osteoclast-poor’’ OPT.
Family studies
Skeletal survey of the parents revealed no significant abnorm-
alities. The mother, 5 feet, 1 inch tall, had brachycephaly and
minimal degenerative changes of L5. The father, a 5 foot, 11 inch
postman, had brachycephaly, spondylolysis of L5, anterior
wedging of T12, and multiple Schmorl’s nodes in his lumbar
and thoracic spine. The patient’s two brothers and three paternal
cousins had several radiographs taken elsewhere following
trauma that were essentially unremarkable.
DXA of the mother showed BMD Z-scores at the upper half of
the age-matched normal range for the L1–L4 spine, total hip,
wrist, and whole body. The father’s values were average for
gender and age.
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mother and father. Respectively, serum TRACP-5b was 3 and
2 U/L (normal 2 to 4 U/L for females and 3 to 5 U/L for males),
osteocalcin 8 and 5ng/mL (normal 3 to 14ng/mL), and BAP 16
and 15 U/L (normal 12 to 31 U/L for females and 15 to 41 U/L
for males). Urine free DPD was 5.0 and 2.9 nmol DPD/mmol of
Cr (normal 3.0 to 7.4 nmol/mmol for females and 2.3 to 5.4 nmol/
mmol for males). The father’s profile suggested low-normal
remodeling.
Mutation analyses
Mutation analysis of the patient’s CLCN7, TCIRG1, and OSTM
genes was notable only for a previously unreported hetero-
Fig. 4. Appendicular skeleton. At 22 (A) and 33 (B) months of age the lower extremities, and at 7 (C) and 33 (D) months of age the left upper extremity,
show sclerosis greatest at the proximal and distal ends of the bones and metaphyseal expansion from tubulation failure greatest in the distal femurs. (E)
There are transverse metaphyseal bands of osteosclerosis, as seen in some forms of OPT (arrows). A healing fracture featuring focal bone expansion and
periosteal new bone formation is present in the distal left femur at the junction of the sclerotic and nonsclerotic bone (arrows)( A). There is a slight
irregularity of the physeal plates and adjacent provisional zones of calcification (C, D, E). Sclerosis in the upper extremities has increased at the ends of the
bones between 7 (C) and 33 (D) months of age. In the leg bones and distal right femur, the junction between the sclerotic and nonsclerotic bone is sharp,
but not well defined in the proximal femurs or distal left femur. The junction between the sclerotic and nonsclerotic bone can have a transverse or
oblique shape.
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noncontributory to the DSS because it occurred in the healthy
father and would affect an amino acid not conserved across
species.
(25)
No mutations were detected in TNFRSF11A, TNFRSF11B, CSF1,
CSF1R,o rANKH. However, in TNFSF11, encoding RANKL, we
found aheterozygous single-base alteration predicting an amino
acid change (c.107C>G, p.Pro36Arg). This missense variation
also was identified in the patient’s father, but not in her mother,
and was not listed in dbSNP,
(26) nor had it been reported in
several association studies of RANKL polymorphisms.
(27,28)
However, we did find it (heterozygous) in 4 of 67 patients [4
of 134 alleles (3.0%)] with a variety of metabolic/dysplastic bone
diseases (see ‘‘Discussion’’) and homozygous in a man with an
unusual, severe variant of Camurati-Engelmann disease.
(29)
Nevertheless, using this candidate gene approach, we did not
identify a causal gene defect for the DSS that we presume was
inherited in this family as an autosomal recessive trait.
Microarray-based genomic copy-number analysis of the patient
and parents also was unrevealing.
Fig. 5. Handandfootradiographs. At22(A)and33(B) monthsofagethelefthandandat 22(C) monthsofagetheleftfootshowdiffusesclerosisgreatest
in the metaphyses of the metacarpals and metatarsals and distal radius and ulna. The amount of sclerosis in the proximal phalanges varies from much to
little and is greatest in the metaphyseal regions. The tarsals have some sclerosis greatest in the cuboids. Pathologic fractures are shown through sclerotic
bone in the distal radius (arrow) and ulna in the anteroposterior projection (D) at 30 months and near nonsclerotic bone in the right femur (arrows)a t
47 months (E).
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Lowering excessive dietary calcium was advised to ensure that
circulating PTH levels were not suppressed and thereby
impairing bone resorption. Following her second inpatient
evaluation, reduction from approximately 950 to 500mg calcium
(RDA) was recommended, but a food record suggested intake of
775mg. Thereafter, even small changes seemed to explain wide
swings in serum PTH levels (Table 1), in keeping with severe
OPT.
(30)
No recommendation was made for bone marrow transplanta-
tion (see ‘‘Discussion’’). Teriparatide was not prescribed, and PTH
seemed ineffective in a previous patient.
(6) Particular attention
was paid to possible surgical intervention if narrowed cranial
foramina caused symptoms.
Literature review
To date, 23 patients are said to have DSS. In 2008, Lemire and
Wiebe
(16) found that 17 patients had been reported with
DSS
(4,6,8–11,15,16,31–35) after Spranger and colleagues
(2) had,
40 years earlier, described their one case, four previously
reported patients from Ellis in 1934 (case 2),
(12) later studied by
Field in 1938,
(13) and one known to Maroteaux and to Stehr in
1942 (case 2).
(36) However, our review showed that the precise
diagnoses of the unusual patients of Chitayat and colleagues
(37)
Fig. 6. Osteoclast-poor osteopetrosis. Sections of the nondecalcified transapophyseal iliac crest biopsy at age 25 months show a growth plate
(A) containing proliferative (Pr) and hypertrophic (Hy) chondrocytes that lack the normal columnar orientation along the axis perpendicular to the
bone surface. In this toluidine-stained section, the bone surface is toward the left, and the chondrocytes should be arranged in rows from left to right.
Scale bar¼200 mm. H&E-stained (B) and toluidine blue–stained (C) sections demonstrate disorganized trabeculae composed primarily of cartilage
(purple in both stains), with only minimal bone matrix (pink in B, pale gray in C). A von Kossa stain (D) shows that the cartilage in these ‘‘trabecular’’ areas is
calcified. TRAP staining (E) fails to identify any osteoclasts. Scale bar (B–E)¼100 mm.
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(38) are somewhat unclear. The
patient ofMaheshwari andcolleagues
(38)seemstohaveatypeof
craniometaphyseal dysplasia. Undoubtedly, there are more
unreported and unrecognized patients. Of historical note, DSS
has previously affected a nonconsanguineous Turkish infant
girl.
(14)
Discussion
Comprehensive investigation of our patient revealed that DSS
presents in infancy as a distinctive ‘‘osteoclast-poor’’ form of OPT
associated with reduced bone remodeling.
History of DSS
DSS was delineated in the German medical literature in 1968
when Spranger and colleagues
(2) described an affected 12-year-
old boy and reviewed five similar pediatric cases.
(12,13,36,39) The
principal radiographic features were osteosclerotic and dysplas-
tic abnormalities in long bones similar to Pyle disease (OMIM %
265900)
(1) but with characteristic platyspondyly and inconsistent
hypoplasia of the iliac bones, also with short stature, bone
fragility, dysodonty, and cranial nerve compression.
(2) By 2008,
there were 23 reported cases.
(4,6,8–11,15,16,31–35) Our literature
review indicated that nearly all represent DSS.
Clinical features of DSS
DSS presents in infancy and is readily distinguished from other
sclerosing bone disorders by its remarkable early acquired
sclerotic platyspondyly, metaphyseal expansion, and demar-
cated osteosclerosis.
(6) Follow-up of one patient
(16) to age
44 years revealed that the widened and osteosclerotic
metaphyseal areas of the long bones seem, unlike most types
of OPT,
(3) to eventually become radiolucent. The patient’s skull,
facial bones, ribs, and spine remain dense, with persisting
platyspondyly and vertebral endplate sclerosis.
(16)
DSS features bowing of long bones, absence of marrow failure
or acroosteolysis,
(38) perhaps skin changes (red-violet spots in a
patchy distribution),
(11–14) developmental regression, and a
variable prognosis. There are reports of dental and enamel
hypoplasiawithdelayedorabsenttootheruptionandpremature
loss of teeth.
(35) The enamel can be irregular and, of interest,
hypercalcified.
(35) The dental manifestations of DSS were
reviewed by Utz in 1970,
(40) and osteomyelitis of the mandible
by Packota and colleagues in 1991.
(7)
Radiographic features of DSS
Major radiographic abnormalities in DSS that change with age
include thickening and sclerosis of the calvarium and base of
the skull, decreased pneumatization of paranasal sinuses and
mastoids, and sclerosis of the scapula, clavicles, and ribs that are
also broad and contain multiple fracture deformities. The pelvic
bones are sclerotic, with the iliac bones having a nonsclerotic
center or the ‘‘bone-in-bone’’ appearance. The vertebrae are
sclerotic and flattened with anterior body wedging. Preadoles-
cent long bone findings include dense sclerosis of epiphyses,
metaphyses that are expanded and club-shaped, but midshafts
that are relatively spared. There is irregularity of the physeal
plates and the adjacent provisional zones of calcification. In
childhood, the hand and foot bones, including the carpals
and tarsals, are sclerotic, with the increased density appearing
greatest at the ends of the tubular bones. The dense, expanded,
Erlenmeyer flask–shaped bone ends evolve into osteopenic
widened bones that include portions of the diaphysis with
thin cortices. Sclerosis remains focal (largely in the metaphyses)
in the long bones, but is present in much of the rest of the
skeleton.
(6,8,16)
Differential diagnosis of DSS
Serial radiographs during infancy should distinguish DSS
from other conditions, including various OPTs, pyknodysostosis,
Camurati-Engelmann disease, and craniometaphyseal dysplasia.
(41)
The especially helpful (diagnostic) feature in DSS is the flattening
of vertebrae with punctate densities. Alternatively, mutation
analysis is available for these other disorders.
For DSS, a severe type of OPT is the principal diagnostic
consideration.
(3) The key features for diagnosis are the spinal
osteosclerosis, flattening, and anterior beaking early on, as well
as the sharply marginated sclerotic and expanded metaphyses.
However, in older (eg, adolescent) DSS patients, osteosclerosis is
replaced by radiolucency in the expanded ends of the tubular
bones.
(6,16) Sclerosis then may involve the diaphyses and appear
only focally in the metaphyses.
Eventually, DSS probably will be diagnosed by mutation
analysis. DSS is considered to be an autosomal recessive trait
(OMIM % 224300).
(1,6) However, X-linked recessive inheritance
seems possible,
(11) although affected girls,
(10,31) such as our
patient, challenge exclusivity for this pattern.
Dysosteosclerosis as a form of osteopetrosis
DSSisnotclassifiedamongtheOPTsbytheInternationalSkeletal
Dysplasia Society.
(42) Yet osteoclast failure is unequivocal in DSS,
with persistence of unresorbed primary spongiosa (calcified
cartilage bars or islands) revealed by iliac crest biopsy. How this
finding occurs with increasing osteosclerosis in most, but not all,
areas of the skeleton remains an enigma. DSS affects especially
endochondral bone formation, but also intramembranous bone
formation
(33) and perhaps development of the teeth.
(4) Our
patient’s sequential radiographs indicated that failed osteoclast
activity began abruptly and then could be profound. Our patient
had bone-within-bone appearances on radiographs (especially
the iliac bones), representing another feature of OPT. Faint
transverse banding in several metaphyseal areas suggested
slight fluctuation of compromised bone remodeling, as can be
seen in Albers-Scho ¨nberg disease (ie, ‘‘benign’’ OPT).
(43) Our
patient’s recurrent fractures through dense bones, as in other
OPTs, probably resulted from retention of cartilage rests, failure
ofosteonstointerconnectduringremodeling,andcompromised
microfracture repair. Our patient also had a pars defect in
keeping with the brittleness of OPT.
(24) Furthermore, in DSS,
bone histology has shown a paucity of both osteoclasts and
osteoblasts
(11) and, after tetracycline double labeling, a miner-
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diffuse tetracycline labels.
(4)
Failure of osteoclast-mediated external shaping of long bones
(modeling or tubulation) in any OPT leads to expanded
metaphyses with an Erlenmeyer flask deformity.
(44) Marrow
cavity compromise occurs because of failure of endosteal bone
resorption,
(45) but to date we have not found dysfunction of
hematopoiesis in our patient. Facial sinuses do not form properly
and aerate, likely explaining her nasal ‘‘stuffiness.’’ Similarly,
neural foramina in the skull do not widen in OPT, but our patient
has not manifested cranial nerve compression.
In our patient, in keeping with her relatively young age of 33 = 4
years, sequential radiographs revealed the increasing metaphy-
seal expansion and osteosclerosis of DSS. Her other major
radiographic changes were sclerosis of the base of her skull and
around the orbits, vertebral body sclerosis with worsening
flattening and anterior pointing, sclerosis of the ribs with loss of
medullary space and multiple healed fractures, long bone
metaphyseal sclerosis, expansion, and failure of modeling. These
findings indicated acquired, early postnatal osteoclast failure. At
age 7 months, our patient’s radiographs showed that ‘‘older’’
skeletal regions contained relatively normal bone. Subsequently,
remarkable demarcation occurred as osteoclast activity failed.
Notably, serum BAP, osteocalcin, and TRACP-5b all were low,
consistent with slow bone remodeling as osteoclast activity
decreased. Absence of osteoclasts would preclude their
signaling to osteoblasts. Our biochemical findings are in keeping
with a postnatal OPT, especially one featuring few osteoclasts,
with low or low-normal serum levels of markers of bone
turnover.
(46) Consonant with reports of DSS, our patient’s
markers of bone remodeling matched her radiographic and
histopathologic findings and indicated suppression of skeletal
turnover, including bone formation. Histopathologic study
revealed an associated defect in mineralization.
Notably, her serum CK-BB was normal, and TRACP-5b was
persistently low in contrast to other forms of OPT
(17) featuring
defects intrinsic to osteoclasts, where CK-BB and TRACP5b are
elevated. Furthermore, unlike in Albers-Scho ¨nberg disease, due
to inactivating mutations in CLCN7, serum LDH and AST levels
were normal (not elevated).
(17)
In DSS, remarkable resolution of appendicular osteosclerosis
over time might question classification as an OPT. However, in
the carbonic anhydrase II (CA II) deficiency form of OPT in which
osteoclasts do not acidify the pericellular milieu, this finding
does occur,
(47) perhaps from the chronic metabolic acidosis.
Our patient did not manifest the renal tubular acidosis that
characterizes CA II deficiency, and therefore CA II levels in
erythrocytes or mutation analysis of CA II were not performed.
The acquired reversal of osteoclast failure in DSS remains
unexplained.
Genetic basis of DSS
Although DSS is extremely rare, autosomal recessive inheritance
seems certain for at least some cases because of reports of
consanguinity.
(15) Our patient’s family history was negative for
consanguinity, which was absent for another Turkish infant girl
with DSS.
(10,14)
No mutations were found in our patient in CLCN7 or TCIRG1,
that account for most human OPT,
(48) or in OSTM1. Unlike most
human forms of OPT, where dysfunctional osteoclasts are
present or abundant,
(46,47) deficiency of osteoclasts appears to
account for OPT in our DSS patient. Osteoclast precursor cells
seem to be available because our patient’s circulating monocyte
counts were repeatedly normal, but we did not test osteoclas-
togenesis from CD14 cells. Insufficiency of osteoclasts causing
OPT has been observed in humans only for RANKL
(21) and
RANK
(48) deficiency (see below). This finding has crucial
therapeutic implications for DSS because bone marrow
transplantation (BMT) might not help.
(46) Accordingly, we
sequenced the exons and splice junctions of TNFRSF11A
(RANK), TNFRSF11B (OPG), and TNFSF11 (RANKL) and found no
mutations.
Because the OPT from an insertion mutation within m-csf in
the op mouse resolves over time,
(49) we studied our patient’s
CSF1 gene encoding M-CSF and the CSF1R gene encoding its
receptorC-FMSbutfoundnoabnormality.Because DSSseemsto
share some of the radiographic features of craniometaphyseal
dysplasia by the teenage years, including metaphyseal widening
and craniofacial sclerosis,
(41) we studied ANKH, but the findings
were unremarkable.
Bone-formation rates are reduced in osteoclast-poor forms of
OPT,accordingtobiochemicalmarkersandhistopathology.
(50)In
fact, markers in our patient were repeatedly remarkable for very
low serum osteocalcin and TRACP-5b levels. However, the high-
bone-density phenotype of the osteocalcin knockout mouse
doesnotappeartobeanOPT.
(51)Hencewedidnotsequenceour
patient’s osteocalcin gene.
RANK gene (TNFRSF11A) analysis was unrevealing for our
patient’s osteoclast-poor OPT. Additionally, there was no
evidence of a TNFSF11 splice site or exonic defect involving
RANKLbutinsteadalikelyrarepolymorphism.Ourpatientcarries
a heterozygous variation (P36R) in RANKL that represents a
nonconservativeaminoacidchangeinaconservedregionofthis
molecule.
(52) P36 is part of a proline-rich region (7 proline
residues/10-amino-acid stretch) near the intracellular side of the
transmembrane domain. However, we do not know of any
function for this 10-amino-acid proline-rich region inRANKL. This
TNFSF11 change was not found in dbSNP
(26) and was not
reported in several association studies of RANKL single-
nucleotidepolymorphisms(SNPs)withbonephenotypes.
(27,28,53)
However, we identified this RANKL variant in 4 of 67
heterozygous patients (or family member) with various bone
diseases and 1 homozygous patient with a unique variant of
Camurati-Engelmann disease,
(29) but a healthy population has
not been screened. It may represent a rare polymorphism
conditioning the DSS phenotype of our patient.
Thus, we were unable to discover a genetic basis for DSS using
this candidate gene approach in this patient. A considerable
number of animal models for OPT lack osteoclasts and thus
provide further candidate genes,
(46,47) including TRAF6, FOS, JUN,
NFATc1, NFkB subunits, and RGS1D.
(42,46) Microarray studies were
not revealing, but homozygosity mapping may be useful. Gene
expressionstudiesusingDSSmonocytesareplanned,whichmay
helptoidentifythegenedefect(s).Negativemutationanalysesin
our single patient do not exclude involvement of the tested
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heterogeneity for this disorder.
Treatment of DSS
Because our patient has osteoclast deficiency, we did not advise
BMT, which has been used for severe OPT when the pathogenic
defect is intrinsic to these cells.
(45,48) In RANKL-deficiency OPT,
where few osteoclasts form, BMT has not been helpful.
(21) In fact,
one DSS patient died at age 10 months from complications of
BMT.
(31) Furthermore, we have not advised teriparatide in part
because of our patient’s paucity of osteoclasts. The patient of
Houston and colleagues
(6) did not respond biochemically with
hypercalcemia, etc. following intramuscular injections of PTH.
Our patient’s management has been largely orthopedic, but we
recommended control of her excessive dietary calcium to ensure
that circulating levels of PTH are not suppressed and thereby
blocking bone resorption. Although the few case reports of DSS
leave much uncertainty concerning the natural history, bone
remodeling may become active later in childhood.
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